AbbVie ABBV
NYSE ABBV
$256.37 -3.84 (-1.48%)
At close: Sep 4, 2026 · 4:00 PM EDT

AbbVie (ABBV) EV to CFO (2012 - 2026)

AbbVie's (ABBV) quarterly EV to CFO came in at 127.52 in Q2 2026, up 104.4% year-over-year from 62.39 in Q2 2025, and up 30.24% quarter-over-quarter from 97.91 in Q1 2026.

Analysis

AbbVie (ABBV) EV to CFO (2012 - 2026) Analysis & Trends

AbbVie (ABBV) has reported EV to CFO for 15 consecutive years, with 127.52 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, EV to CFO rose 104.4% year-over-year to 127.52 in Q2 2026; TTM through Jun 2026 was 22.46, a 34.73% increase from a year earlier, with the FY2025 full-year figure at 20.96, up 27.88% from the prior year.
  • EV to CFO was 127.52 for Q2 2026 at AbbVie, up from 97.91 in the prior quarter.
  • Over five years, EV to CFO peaked at 223.22 in Q1 2025 and troughed at 29.66 in Q3 2022.
  • A 5-year average of 73.31 and a median of 59.92 in 2025 frame the typical range for EV to CFO.
  • Across the five-year window, EV to CFO surged 252.07% in 2024 and slumped 56.14% in 2026, its largest moves.
  • Over 5 years, EV to CFO stood at 37.26 in 2022, then soared by 47.37% to 54.91 in 2023, then dropped by 20.36% to 43.73 in 2024, then surged by 74.78% to 76.43 in 2025, then surged by 66.85% to 127.52 in 2026.
  • The last three EV to CFO figures came in at 127.52 (Q2 2026), 97.91 (Q1 2026), and 76.43 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn -
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn
10 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 127.52
Mar 31, 2026 97.91
Dec 31, 2025 76.43
Sep 30, 2025 57.46
Jun 30, 2025 62.39
Mar 31, 2025 223.22
Dec 31, 2024 43.73
Sep 30, 2024 62.74
Jun 30, 2024 127.63
Mar 31, 2024 75.13
Dec 31, 2023 54.91
Sep 30, 2023 33.00
Jun 30, 2023 36.25
Mar 31, 2023 65.46
Dec 31, 2022 37.26
Sep 30, 2022 29.66
Jun 30, 2022 52.12
Mar 31, 2022 56.83
Dec 31, 2021 45.26
Sep 30, 2021 22.49